Vivos Inc (RDGL)

$0.12 +0.00 (1.97%)
Market Cap 52.93M
Revenue (ttm) 30,000.00
Net Income (ttm) -2.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,700.00%
Debt to Equity Ratio 0.00
Volume 688,500
Avg Vol 730,450
Day's Range N/A - N/A
Shares Out 453.51M
Stochastic %K 19%
Beta 1.06
Analysts Strong Buy
Price Target N/A

Company Profile

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing a universal laboratory cooling device; hydro...

Industry: Medical Devices
Sector: Healthcare
Phone: 509 222 2222
Address:
1030 N Center Parkway, Suite N288, Kennewick, United States
Rogggggg
Rogggggg Jun. 26 at 11:11 PM
$RDGL hypothetically it would make sense don’t you think?
1 · Reply
Rogggggg
Rogggggg Jun. 26 at 11:08 PM
$RDGL random Friday news drop catch everyone by surprise? 🤑🤪 doubt it but we can all hope…
0 · Reply
Daybyday5
Daybyday5 Jun. 26 at 6:38 PM
$RDGL can’t wait to see how much of the offering has been sold after 10q. Hope they have enough to fund the trials
0 · Reply
Rogggggg
Rogggggg Jun. 26 at 2:33 PM
$RDGL 16k volume… smh
1 · Reply
Daybyday5
Daybyday5 Jun. 26 at 1:39 PM
$RDGL hope we won't be like $ALT on or before July 14th :)
0 · Reply
jhmlty
jhmlty Jun. 25 at 9:59 PM
$RDGL 18 days
0 · Reply
zoomnewm
zoomnewm Jun. 25 at 9:56 PM
$RDGL https://x.com/isopetforcancer/status/1937961688525115861?s=61
0 · Reply
Barzimeron
Barzimeron Jun. 24 at 5:34 PM
$RDGL So got half of what I need to make my next Target. Never owned this much of any one stock before.
2 · Reply
twighttrades1
twighttrades1 Jun. 24 at 2:54 PM
$RDGL - seeing nice size bids pop up… 360k worth all of a sudden
1 · Reply
GRIG330
GRIG330 Jun. 23 at 8:22 PM
$RDGL BULLISH AF
0 · Reply
Latest News on RDGL
No data available.
Rogggggg
Rogggggg Jun. 26 at 11:11 PM
$RDGL hypothetically it would make sense don’t you think?
1 · Reply
Rogggggg
Rogggggg Jun. 26 at 11:08 PM
$RDGL random Friday news drop catch everyone by surprise? 🤑🤪 doubt it but we can all hope…
0 · Reply
Daybyday5
Daybyday5 Jun. 26 at 6:38 PM
$RDGL can’t wait to see how much of the offering has been sold after 10q. Hope they have enough to fund the trials
0 · Reply
Rogggggg
Rogggggg Jun. 26 at 2:33 PM
$RDGL 16k volume… smh
1 · Reply
Daybyday5
Daybyday5 Jun. 26 at 1:39 PM
$RDGL hope we won't be like $ALT on or before July 14th :)
0 · Reply
jhmlty
jhmlty Jun. 25 at 9:59 PM
$RDGL 18 days
0 · Reply
zoomnewm
zoomnewm Jun. 25 at 9:56 PM
$RDGL https://x.com/isopetforcancer/status/1937961688525115861?s=61
0 · Reply
Barzimeron
Barzimeron Jun. 24 at 5:34 PM
$RDGL So got half of what I need to make my next Target. Never owned this much of any one stock before.
2 · Reply
twighttrades1
twighttrades1 Jun. 24 at 2:54 PM
$RDGL - seeing nice size bids pop up… 360k worth all of a sudden
1 · Reply
GRIG330
GRIG330 Jun. 23 at 8:22 PM
$RDGL BULLISH AF
0 · Reply
Doccjc62
Doccjc62 Jun. 22 at 3:18 PM
$RDGL Great Post from another board . The Tipping Point: RadioGel Is About to Change Everything. To those watching from the sidelines, wondering if Vivos Inc. (RDGL) and its flagship cancer-fighting technology RadioGel® are worth the investment — let me make this crystal clear: We are now standing on the doorstep of FDA IDE (Investigational Device Exemption) submission. After years of R&D, animal studies, dosimetry testing, safety validation, radiation delivery modeling, and navigating every regulatory hurdle the FDA has thrown their way, Vivos is preparing to submit what could be the final sprint package that opens the gates to human trials. Let that sink in: We are potentially weeks, not years, away from the FDA greenlighting the use of RadioGel in human cancer patients.
2 · Reply
Doccjc62
Doccjc62 Jun. 20 at 6:46 PM
$RDGL Could next week be the week ? Company has hinted it could be earlier . Data from the India human trials will only strengthen the IDE to be submitted . LFG
0 · Reply
zoomnewm
zoomnewm Jun. 20 at 2:16 PM
$RDGL https://x.com/isopetforcancer/status/1936059502392230377?s=61
0 · Reply
jhmlty
jhmlty Jun. 19 at 1:45 PM
$RDGL 24 Days until FDA submission according to the good doctor.
0 · Reply
Doccjc62
Doccjc62 Jun. 19 at 2:21 AM
$RDGL Market makers were selling 2600 or so shares at the bid every 6 minutes today. Yesterday it was every 16 minutes. They executed a last second sell to close us at the LOD. The MM's wanted it lower today and they are in control right now. That's about to change imo. I bet we see an early IDE submission and it wouldn't surprise me to see a nice run up during the 30 day decision period. This could all start next week imo.
2 · Reply
WhatTheFinger
WhatTheFinger Jun. 18 at 8:04 PM
$RDGL fking bullshit. Promise us with a good day, then pull the rug out the next. Just fking ridiculous action sometimes.
4 · Reply
TradingTomo
TradingTomo Jun. 18 at 7:49 PM
$RDGL
0 · Reply
BullIsBest
BullIsBest Jun. 18 at 7:25 PM
$RDGL My App says 60,000 shares traded at 2 pm EST. ~$7500. Stock price really doesn't matter at that volume. Looks like most are holding until there is some news
0 · Reply
Satelliteswing
Satelliteswing Jun. 18 at 6:29 PM
$RDGL
2 · Reply
Daybyday5
Daybyday5 Jun. 18 at 4:43 PM
$RDGL I wonder what yesterday's hype was all about
1 · Reply
anderson800
anderson800 Jun. 18 at 12:50 PM
$RDGL I sent a message to Vivos to ask is they can confirm which is correct. Perhaps if they are planning to submit before the end of the quarter as stated on their Road to IDE Submission, they expect to have a response back from FDA by mid July. They like surprising us.
2 · Reply
anderson800
anderson800 Jun. 18 at 12:36 PM
$RDGL I knew I remembered they had said submitting in 2nd Quarter at one time and finally found where it said that. The road to IDE. "Vivos Inc is scheduled to submit RadioGel as an Early Feasibility IDE Application in the second quarter".
3 · Reply